President and CEOOfficers of the CorporationBoard of TrusteesLeadership CouncilHistory
Managing DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsInfo for Healthcare ProfessionalsJoslin Clinical Guidelines50-Year Medalist Program
Adult ClinicPediatricsEye CareBillingInfo for Healthcare ProfessionalsDiabetes Information & Resources
Directory of Joslin InvestigatorsDiabetes Research Center Alumni Connection
Media RelationsNews ReleasesInside JoslinSocial Media
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternational
Give NowHow You Can Help JoslinHigh Hopes FundGet InvolvedEventsCorporate & Foundation SupportPlanned GivingPhilanthropy Team

Christophe Benoist, Ph.D.

We explore how T cells differentiate into their different lineages and final effector states, particularly from the standpoint of self-tolerance and autoimmunity. Studies on autoimmunity explore the molecular and genetic failures of tolerance in diabetes, rheumatoid arthritis and in the disease that appears in Aire-deficient individuals. Major questions tackled are why thymic tolerance is defective in these models, what triggers the autoimmune processes, how their progression is regulated. We ask where and how regulatory “Treg” cells are generated and control autoimmune destruction in mouse models and in human patients.

 

Molecular investigations tackle how the Aire transcription factor controls the ectopic expression of self-antigens in the thymus, or how FoxP3 coordinates with other elements in specifying the different facets of the Treg phenotype. Our research involves many collaborations across the campus, and a wide range of technologies are applied to these questions (manipulation of the mouse germline, gene expression profiling, mass spectrometry, RNAi screens). Imaging tools are used to analyze and track autoimmune inflammation in vivo, in mice and human patients. The lab also has an interest in bioinformatic approaches to explore the regulation and connectivity of gene expression at the “Systems Immunology” level being one of the leads of the Immunological Genome explorations in mice and human cells (www.immgen.org).

Page last updated: December 17, 2017